AzTrials
AzTrials

MalocclusionNCT06123585

Artificial Intelligence (AI) Empowered Smile Simulations: Do They Accurately Predict Actual Post Treatment Outcomes

A study testing Invisalign® SmileView™ and Invisalign aligners in people with Malocclusion, run by Nourhan M.Aly at 1 site in United Arab Emirates.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of the present study is to assess the predictability of Invisalign® SmileView™ for digital AI smile simulation in comparison to actual smile treatment outcomes, using various smile assessment parameters. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Malocclusion
What is being tested?
Invisalign® SmileView™ and Invisalign aligners
Could I receive a placebo?
No, everyone receives an active treatment
How many people
24 participants
Where
1 siteUnited Arab Emirates
Study dates
1 Jan 2018to 5 Jul 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • healthy systemic condition with no chronic diseases
  • no previous orthodontic treatment
  • adequate oral hygiene
  • a healthy periodontium.

Who cannot join

  • chronic diseases
  • previous orthodontic treatment
  • poor oral hygiene
  • periodontal diseases

Trial locations and contacts

1 site in 1 country.

United Arab Emirates1 site
  • Private orthodontic offices of Invisalign Diamond Plus Elite

    Dubai

Other trials in United Arab Emirates

About this study

The aim of the present study is to assess the predictability of Invisalign® SmileView™ for digital AI smile simulation in comparison to actual smile treatment outcomes, using various smile assessment parameters.

Conditions
Malocclusion
Being tested
Invisalign® SmileView™, Invisalign aligners
Medical subject headings
Malocclusion

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Invisalign® SmileView™Other

    Pretreatment smiles were captured using the Invisalign® SmileView™ to simulate their new smiles before treatment was started.

  • Invisalign alignersOther

    Patients were then treated using upper and lower Invisalign aligners with average treatment time of 12±3 months.

Study groups in NCT06123585
Study groupRoleWhat they receive
Invisalign® SmileView™ExperimentalNot described
Receives: Other: Invisalign® SmileView™
Invisalign alignersActive comparatorNot described
Receives: Other: Invisalign aligners

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Smile line

    The extent of the vertical tooth display on smiling or the elevation of the upper lip in relation to the maxillary incisors. Three types of smile lines have been described- high, average, and low. A high smile shows the maxillary anterior teeth along with a significant amount of gingiva, an average smile shows maxillary anterior teeth with only interproximal gingiva, and a low smile typically shows less than two-thirds of the maxillary anterior teeth

    Measured: through study completion, an average of 1 year

  2. Smile arc

    The relationship between the curvature of the maxillary anterior teeth and upper border of the lower lip. It is defined by drawing a line along the maxillary central incisal edges to the cusp tips of maxillary canines, which is related to another line drawn across the superior border of the lower lip. In subjects whose maxillary teeth are covered by lower lip, smile arc is designated as "not available". Three types of smile arcs have been described- "parallel to the teeth" (when the two lines follow the same curvature) also called a consonant smile, and a non-consonant smile, if the two lines are not parallel. A non-consonant smile can either be "straight" (with flatter curvature of the maxillary anterior teeth in relation to the lower lip) or "reverse" (when the maxillary anterior teeth form a reverse curve in relation to lower lip).

    Measured: through study completion, an average of 1 year

  3. The most posterior teeth displayed

    Smiles are categorized as displaying teeth up to the canines, first premolars, second premolars, or the first molars. A tooth is counted when more than half of its surface is visible.

    Measured: through study completion, an average of 1 year

  4. The philtrum height

    Distance measured in millimeters from subspinale (the base of the nose at the midline) to the most inferior portion of the upper lip on the vermilion tip beneath the philtral columns

    Measured: through study completion, an average of 1 year

  5. Commissure height

    Distance measured in millimeters from a line constructed from the alar bases through subspinale and then from the commissures perpendicular to this line. The differential lip growth exhibits the difference in height in philtrum and commissural height in adolescents.

    Measured: through study completion, an average of 1 year

  6. Smile width/Inter-commissure width

    The distance (mm) from outer commissure to outer commissure on smile in millimeters.

    Measured: through study completion, an average of 1 year

  7. Smile index

    The ratio between the horizontal smile width and the vertical smile height during smiling (smile width/smile height).

    Measured: through study completion, an average of 1 year

  8. Maxillary inter-canine width

    distance from the distal aspect of the right canine to the distal aspect of the left canine in millimeters

    Measured: through study completion, an average of 1 year

  9. Buccal corridor

    It is the space created between the buccal surface of the posterior teeth and the lip corners when the patient smiles. Orthodontists often refer to buccal corridors as "negative spaces". The buccal corridor is measured from the mesial line angle of the maxillary first premolars to the interior portion of the commissure of the lips. Moore et al [16]. have previously quantified a buccal corridor of 28% as medium-narrow, 15% as medium, 10% as medium-broad, and 2% as broad smile fullness

    Measured: through study completion, an average of 1 year

  10. Amount of lower incisor show

    The amount of lower incisor display which can be categorized into either 1) No show of lower incisors during smiling, 2) partial lower incisor exposure or 3) full length lower incisor exposure.

    Measured: through study completion, an average of 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Nov 2023
  2. Study start1 Jan 2018
  3. Primary completion1 Jul 2020
  4. Study completion5 Jul 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Non-randomised
Intervention model
Sequential
Masking
None (open label)
Enrolment
24 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06123585
Sponsor's protocol ID
SRB/SDC/ORTHO-2119/23/019
Status last verified
Nov 2023
First submitted
1 Nov 2023
Last updated
9 Nov 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Adel SM, Bichu YM, Pandian SM, Sabouni W, Shah C, Vaiid N. Clinical audit of an artificial intelligence (AI) empowered smile simulation system: a prospective clinical trial. Sci Rep. 2024 Aug 21;14(1):19385. doi: 10.1038/s41598-024-69314-6.

    PubMed 39169095

Questions about this trial

What is this clinical trial studying?

A study testing Invisalign® SmileView™ and Invisalign aligners in people with Malocclusion, run by Nourhan M.Aly at 1 site in United Arab Emirates.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Arab Emirates. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Smile line (time frame: through study completion, an average of 1 year). The study lists 10 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06123585, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Nov 2023; AzTrials last refreshed its copy on 28 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in